Stockreport

Xenon: Shares Soar On Seizure Data, But Valuation May Be Overcooked [Seeking Alpha]

Xenon Pharmaceuticals Inc. - Common Shares  (XENE) 
Last xenon pharmaceuticals inc. - common shares earnings: 11/5 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.xenon-pharma.com
PDF XENE plans an NDA submission for azetukalner in Q3 2026, targeting both epilepsy and neuropsychiatric indications, with additional pivotal trials ongoing. Despite rob [Read more]